Alan Bell

13.0k total citations
53 papers, 997 citations indexed

About

Alan Bell is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Alan Bell has authored 53 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 12 papers in Internal Medicine. Recurrent topics in Alan Bell's work include Venous Thromboembolism Diagnosis and Management (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Alan Bell is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Alan Bell collaborates with scholars based in Canada, United States and United Kingdom. Alan Bell's co-authors include Jonathan D. Adachi, Vivien Brown, David A. Hanley, Andrew McIvor, James D. Douketis, André Roussin, Raymond Cartier, Jean‐François Tanguay, Wee‐Shian Chan and Meyer Balter and has published in prestigious journals such as The American Journal of Cardiology, British Journal of Anaesthesia and Canadian Medical Association Journal.

In The Last Decade

Alan Bell

51 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Bell Canada 14 342 270 208 199 137 53 997
J. Green United Kingdom 6 183 0.5× 205 0.8× 401 1.9× 129 0.6× 107 0.8× 7 1.2k
Matteo Nardin Italy 21 583 1.7× 283 1.0× 131 0.6× 47 0.2× 69 0.5× 106 1.1k
Bent Lind Denmark 21 600 1.8× 182 0.7× 56 0.3× 165 0.8× 143 1.0× 78 1.8k
Lucia Barbieri Italy 23 880 2.6× 502 1.9× 235 1.1× 53 0.3× 85 0.6× 114 1.6k
Edward Horwitz United States 15 340 1.0× 230 0.9× 172 0.8× 59 0.3× 292 2.1× 30 1.9k
Lingsong Yun Canada 18 498 1.5× 236 0.9× 294 1.4× 41 0.2× 86 0.6× 43 1.0k
Alex Disney Australia 21 350 1.0× 337 1.2× 188 0.9× 33 0.2× 273 2.0× 48 2.1k
Frances Dockery United Kingdom 15 208 0.6× 132 0.5× 146 0.7× 147 0.7× 203 1.5× 38 1.0k
Roberta Florido United States 14 860 2.5× 139 0.5× 344 1.7× 22 0.1× 85 0.6× 45 1.3k
Fabrice Mac‐Way Canada 19 359 1.0× 299 1.1× 163 0.8× 250 1.3× 187 1.4× 85 1.2k

Countries citing papers authored by Alan Bell

Since Specialization
Citations

This map shows the geographic impact of Alan Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Bell more than expected).

Fields of papers citing papers by Alan Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Bell. The network helps show where Alan Bell may publish in the future.

Co-authorship network of co-authors of Alan Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Bell. A scholar is included among the top collaborators of Alan Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Bell. Alan Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kosowan, Leanne, Alan Bell, Kim A. Connelly, et al.. (2023). Validation of a Case Definition to Identify Patients Diagnosed With Cardiovascular Disease in Canadian Primary Care Practices. CJC Open. 5(7). 567–576. 3 indexed citations
2.
Bell, Alan, et al.. (2023). Approach to atrial fibrillation. Canadian Family Physician. 69(4). 245–256. 3 indexed citations
3.
Watson, Kaitlyn E., et al.. (2021). Assessment of the educational competencies for the Hypertension Canada Professional Certification Program (HC-PCP) designed for implementation of hypertension guidelines into primary care. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 154(4). 271–277. 1 indexed citations
4.
Brown, Jacques P., Jonathan D. Adachi, Emil H. Schemitsch, et al.. (2021). Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario. BMC Musculoskeletal Disorders. 22(1). 105–105. 57 indexed citations
5.
Leung, Alexander A. C., Alan Bell, Ross T. Tsuyuki, & Norman R.C. Campbell. (2021). Refocusing on hypertension control in Canada. Canadian Medical Association Journal. 193(23). E854–E855. 12 indexed citations
6.
Παπαϊωάννου, Αλεξάνδρα, Eugène McCloskey, Alan Bell, et al.. (2021). Use of an electronic medical record dashboard to identify gaps in osteoporosis care. Archives of Osteoporosis. 16(1). 76–76. 4 indexed citations
7.
Gross, Peter L., et al.. (2021). Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thrombosis Research. 202. 176–181. 1 indexed citations
9.
Leblanc, Kori, Alan Bell, Justin A. Ezekowitz, et al.. (2020). Non‐vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme. International Journal of Clinical Practice. 74(12). e13625–e13625. 5 indexed citations
10.
Gupta, Milan, et al.. (2020). Physician Perspectives on the Diagnosis and Management of Heart Failure With Preserved Ejection Fraction. CJC Open. 3(3). 361–366. 7 indexed citations
12.
Woo, Vincent, Alan Bell, Maureen Clement, et al.. (2019). CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice. Canadian Journal of Diabetes. 43(7). 464–471. 4 indexed citations
13.
Woo, Vincent, Alan Bell, Maureen Clement, et al.. (2018). CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice. Diabetes Obesity and Metabolism. 21(3). 691–699. 9 indexed citations
15.
Douketis, James D., Alan Bell, John W. Eikelboom, & Aaron Liew. (2014). Approche à l’égard des nouveaux anticoagulants oraux en pratique familiale 2e partie : Répondre aux questions souvent posées. Canadian Family Physician. 60(11).
16.
Fitchett, David, Atul Verma, John W. Eikelboom, et al.. (2013). Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation. Current Opinion in Cardiology. 29(1). 1–9. 6 indexed citations
17.
Tanguay, Jean‐François, Alan Bell, Margaret L. Ackman, et al.. (2013). Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy. Canadian Journal of Cardiology. 29(11). 1334–1345. 75 indexed citations
18.
Hanley, David A., Jonathan D. Adachi, Alan Bell, & Vivien Brown. (2012). Denosumab: mechanism of action and clinical outcomes. International Journal of Clinical Practice. 66(12). 1139–1146. 244 indexed citations
19.
Bell, Alan, André Roussin, Raymond Cartier, et al.. (2011). The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary. Canadian Journal of Cardiology. 27(2). 208–221. 41 indexed citations
20.
Kaplan, Alan, et al.. (2009). Diagnosis of asthma in adults. Canadian Medical Association Journal. 181(10). E210–E220. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026